OPC18750 HCl

CAS No. 145364-90-5

OPC18750 HCl( —— )

Catalog No. M37364 CAS No. 145364-90-5

OPC18750 HCl is a potential phosphodiesterase inhibitor with positive inotropic effects that can be used to study asthma, cancer, diabetes, and psychiatric disorders.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 296 Get Quote
5MG 459 Get Quote
10MG 657 Get Quote
25MG 994 Get Quote
50MG 1371 Get Quote
100MG 1773 Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    OPC18750 HCl
  • Note
    Research use only, not for human use.
  • Brief Description
    OPC18750 HCl is a potential phosphodiesterase inhibitor with positive inotropic effects that can be used to study asthma, cancer, diabetes, and psychiatric disorders.
  • Description
    OPC18750 HCl is a potential phosphodiesterase inhibitor with positive inotropic effects that can be used to study asthma, cancer, diabetes, and psychiatric disorders.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Angiogenesis
  • Target
    PDE
  • Recptor
    PDE
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    145364-90-5
  • Formula Weight
    390.86
  • Molecular Formula
    C20H23ClN2O4
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    Cl.O=C1C=CC=2C=C(OCC(O)CNCC=3C=CC=C(OC)C3)C=CC2N1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Lodenafil

    Lodenafil is a potent PDE5 inhibitor with treatment of erectile dysfunction (ED).

  • Cilomilast

    A potent and selective PDE4 inhibitor with IC50 of 95/120 nM for LPDE4/HPDE4.

  • N-Ethyl tadalafil

    N-Ethyl tadalafil (NEthyl tadalafil) is a CGMP-specific 3',5'-cyclic phosphodiesterase (PDE) inhibitor used in the study of cardiovascular diseases such as angina pectoris, hypertension, and pulmonary hypertension.